Skip to content

Author

Ayrton I. Bangolo

We have 2 of 108 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

T-cell redirecting therapies in lung cancer - a comprehensive analysis of clinical trials

T cell-redirected therapy is positioned to extend the survival frontier for patients whose lung cancer has escaped existing treatments, and combination strategies pairing T cell-redirected therapies with ICIs, antibody-drug conjugates, and allogeneic or innate immune effectors represent the most promising path toward d...

Jia-He Zhao, Ayrton I. Bangolo, Li-Li Zhang et al. · 0 citations
Review Open access Sep 2026

Survival outcome of Gallbladder cancer in the US: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities

Male gender, older age, and distant tumor stage are significant predictors of higher mortality, while chemotherapy and surgery substantially improve survival in GBC patients, highlighting the necessity for targeted interventions and personalized treatment approaches to enhance survival rates.

Ayrton I. Bangolo, Behzad Amoozgar, B. Alqinai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.